The role of ovarian transposition in patients with early stage cervical cancer - two case reports

The aim of the study is to present two cases of premenopausal women with early stage cervical carcinoma who underwent ovarian transposition. The role and the advantages of this technique are discussed.

Early stage cervical carcinoma; Ovarian transposition; Preservation; Menopause; Fertility

[1] DeCherney A., Nathan A. (eds.) Current Obstetric and Gynecologic Diagnosis and Treatment, 9th edition, New York, McGraw Hill, 2003.

[2] Duska L.R., Toth T.L., Goodman A.: “Fertility options for patients with Stages IA2 and IB cervical cancer: presentation of two cases and discussion of technical and ethical issues”. Obstet. Gynecol., 1998, 92 (4 pt 2), 656.

[3] Sella T., Mironov S., Hricak H.: “Imaging of transposed ovaries in patients with cervical carcinoma”. AJR, 2005, 184, 1602.

[4] Morice P., Juncker L., Rey A., El-Hassan J., Haie-Meder C., Castaigne D.: “Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination”. Fertil. Steril., 2000, 74, 743.

[5] Ishii K., Aoki Y., Takakuwa K., Tanaka K.: “Ovarian function after radical hysterectomy with ovarian preservation for cervical cancer”. J. Reprod. Med., 2001, 46, 347.

[6] Olejek A., Wala D., Chimiczewski P., Rzempoluch J.: “Hormonal activity of transposed ovaries in young women treated for cervical cancer”. Gynecol. Endocrinol., 2001, 15, 5.

[7] Wu X.H., Li Z.T., Huang X., Zhou Y.Q., Cheng X., Cai S.M., Zhang Z.Y.: “Transposed ovarian function conservation in cervical cancer patients with radiotherapy”. Zhonghua Fu Chan Ke Za Zhi., 2005, 40, 220.

[8] Buekers T.E., Anderson B., Sorosky J.I., Buller R.E.: “Ovarian function after surgical treatment for cervical cancer”. Gynecol. Oncol., 2001, 80, 85.

[9] Feeney D.D., Moore D.H., Look K.Y., Stehman F.B., Sutton G.P.: “The fate of the ovaries after radical hysterectomy and ovarian transposition”. Gynecol. Oncol., 1995, 56, 3.

[10] Bidzin´ski M, Lemieszczuk B, Zielin´ski J.: “Evaluation of the hormonal function and features of the ultrasound picture of transposed ovary in cervical cancer patients after surgery and pelvic irradiation”. Eur. J. Gynaecol. Oncol., 1993, 14 (suppl.), 77.

[11] Van Eijkeren M.A., Van Der Wijk I., El Sharouni S.Y., Heintz A.P.: “Benefits and side effects of lateral ovarian transposition (LOT) performed during radical hysterectomy and pelvic lymphadenectomy for early stage cervical cancer”. Int. J. Gynecol. Cancer., 1999, 9, 396.

[12] Olejek A., Rzempoluch J., Adamczyk S., Binkiewicz P., Chimiczewski P.: “Surgical procedure connected complications in women with cervical cancer operated with ovarian transposition (transpositio ovariorum)”. Ginekol. Pol., 1998, 69, 644.

[13] Owens S., Roberts W.S., Fiorica J.V., Hoffman M.S., LaPolla J.P., Cavanagh D.: “Ovarian management at the time of radical hysterectomy for cancer of the cervix”. Gynecol. Oncol., 1989, 35, 349.

[14] Nguyen L., Brewer C.A., DiSaia P.J.: “Ovarian metastasis of Stage IB1 squamous cell cancer of the cervix after radical parametrectomy and oophoropexy”. Gynecol. Oncol., 1998, 68, 198.

[15] Landoni F., Zanagnolo V., Lovato-Diaz L., Maneo A., Rossi R., Gadducci A. et al.: “Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study)”. Int. J. Gynecol. Cancer, 2007, 17, 623.